Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c335b7f192e127235e07021d81354d82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_960d11df1b8103530d1d64cf274973a5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e780956903ce5ba2fcba0cfee365ac8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_351f329bfa5cdc6a5ec586cb0de8dce4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9a4e6ed143ad7258bb1a05174772849 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f34119b232d292c72e632b62008eca90 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-37252 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36542 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36557 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36514 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3702 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-372 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-365 |
filingDate |
2007-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_876d38c69066a58a0f077f4ec2d12e64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17bf7d9b7b4d835914a06567859158fb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca500491af6bc988ce5adf1a48828db9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a0bbfda3fc5b8222f3843c0b1a005fb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c70f51a96ffec117a2829034dca950fd |
publicationDate |
2007-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2007124238-A1 |
titleOfInvention |
Implantable medical device with automatic ischemia threshold determination |
abstract |
An implantable medical device (IMD) performs periodic testing of a patient to determine ischemia threshold information. At selected times while the patient is at rest, the IMD increases the pacing rate over time until it receives feedback either from the patient or from an ischemia sensor. The IMD determines the threshold based upon the pacing rate at the time when the feedback was received. The threshold information can be used to adjust the upper pacing rate that can be used during rate adaptive pacing, to determine the effects of drug therapy, and to provide a general indication of the state of coronary artery disease in the patient. The periodic increase of pacing rate to the ischemic zone also provides a preconditioning of the myocardium to allow the patient greater exercise benefit without angina. |
priorityDate |
2006-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |